The safety of drugs for inflammatory bowel disease during pregnancy and breastfeeding: the DUMBO registry study protocol of GETECCU

Background: Active disease during conception and pregnancy in women with inflammatory bowel disease (IBD) increases the risk of pregnancy complications and adverse neonatal outcomes. The use of IBD treatments during pregnancy should be weighed against their adverse effects on the neonate, but longer...

Descripció completa

Dades bibliogràfiques

Autors principals:	María Chaparro, María G. Donday, Francisco Abad-Santos, Francisco Javier Martín de Carpi, Miguel Ángel Maciá-Martínez, Dolores Montero, Diana Acosta, Yanire Brenes, Javier P. Gisbert
Format:	Artigo
Idioma:	Inglês
Publicat:	SAGE Publishing 2021-06-01
Col·lecció:	Therapeutic Advances in Gastroenterology
Accés en línia:	https://doi.org/10.1177/17562848211018097
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!